All studies
Active not recruitingNAINTERVENTIONAL

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

This study, called ACURATE IDE, aimed to check how safe and effective a special heart valve, the ACURATE valve, was. It was designed for people with a serious condition called aortic stenosis, where the heart's main valve doesn't open properly. The study compared the ACURATE valve against other well-known valves like the SAPIEN 3 and CoreValve systems, which are already used for a keyhole procedure called TAVR. The goal was to see if the ACURATE valve could help patients just as much. The study was planned to involve many people across different countries. However, please note that the company making the ACURATE valve has decided to stop producing it and won't be seeking approval for its use in new areas.

At a glance

Status
Active not recruiting
Phase
NA
Sponsor
Boston Scientific Corporation
Enrolment target
1,948
Start
10 Jun 2019
Estimated completion
01 Sep 2029

Results

Results from this study

Posted April 2025

Results have been published for this study.

Primary outcome
Composite Rate of All-cause Mortality, All Stroke, and Rehospitalization* at 1 Year in the Main Randomized Cohort.
Primary Endpoint: A Clinical Events Committee (CEC), independent group of physician experts reviewed and adjudicated all reported cases of death, stroke and rehospitalization to determine whether they met the specific protocol definition of the event. The CEC adjudicated results are used in the endpoint analysis. \* Hospitalization for valve-related symptoms or worsening congestive heart failure (NYHA class III or IV); per VARC-2 definition.
Full results on the registry

What is this study about?

This study, called ACURATE IDE, was designed to investigate a new type of heart valve called the ACURATE valve. It was for people who have a serious heart problem called aortic stenosis. This condition means the main valve in your heart, called the aortic valve, has become stiff and narrow, making it hard for blood to flow out to the rest of your body. This can make you feel very tired, breathless, or even have chest pain, especially when you're active. The study focused on using a 'keyhole' procedure, known as TAVR (Transcatheter Aortic Valve Replacement), to fit the new valve. This procedure is less invasive than traditional open-heart surgery.

The main aim of the study was to see if the ACURATE valve was as safe and effective as other heart valves that are already widely used for TAVR. This comparison helps doctors understand if new treatments are a good option for patients. The study planned to compare the ACURATE valve against two well-known valves, the SAPIEN 3 and the CoreValve systems. By comparing them, the researchers hoped to gather important information about how well the ACURATE valve worked and if it had similar benefits and risks to existing treatments.

It's important to know that while this study gathered valuable information, the company that made the ACURATE valve has since decided to stop producing it globally. This means that even though the study was conducted, the ACURATE valve is no longer available. This information is provided to help you understand past research, but it does not mean the ACURATE valve is a current treatment option.

Key takeaways

  • The ACURATE IDE study investigated a new heart valve for aortic stenosis.
  • It aimed to compare the ACURATE valve against other established heart valves.
  • The study used a minimally invasive procedure called TAVR.
  • While the study provided data, the ACURATE valve has been discontinued and is no longer available.
  • Studies like this help improve our understanding of heart valve treatments.

Who may be eligible?

To be considered for a study like this, certain health conditions or features would typically need to be present. For this study, you would have needed to have a severe narrowing of your aortic valve, diagnosed by heart scans like an echocardiogram. This narrowing would have caused noticeable symptoms like breathlessness or tiredness, falling into a certain category of heart failure symptoms (NYHA Functional Class II or worse).

Additionally, your heart doctor and heart surgeon would both need to agree that replacing your aortic valve using the minimally invasive TAVR procedure was the right treatment for you and that you would likely benefit from it. Your heart's main valve, the aortic annulus, would also need to be a specific size to fit the study's valves. You also needed to be able to understand the study, agree to participate, and come back for all your follow-up appointments. You would also need to be able to take any necessary medicines prescribed as part of the study.

However, there were certain reasons you couldn't join. For example, if you had an aortic valve with only one or two leaflets instead of the usual three, or if you had recently had a heart attack within the last month, you wouldn't have been eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Do you have severe narrowing of your aortic heart valve?
  2. Are you experiencing symptoms like breathlessness or tiredness due to your heart condition?
  3. Have your heart doctors recommended a valve replacement procedure for you?
  4. Are you able to attend all required follow-up appointments?
  5. Could you take any necessary medications as prescribed by the study doctors?
Answer every question to see your result.

What does participation involve?

If you had joined this study, you would have been carefully assessed to ensure the study was right for you. Your journey might have involved being in a group where you received the ACURATE valve, or a group receiving one of the other established valves, decided randomly, like tossing a coin. You would have had several visits to the hospital for assessments before and after your valve replacement procedure.

Some parts of the study involved closer monitoring. For example, some participants had special 4D CT scans (a detailed type of X-ray) to look very closely at the new valve and how it was working. There was also a smaller group for a different version of the ACURATE valve. All participants would have been asked to take specific medications as directed by the study doctors. You would have been asked to return to the hospital for scheduled follow-up visits after your procedure to check on your health and how the new valve was performing over time. The overall duration of your participation would have depended on the study's follow-up schedule.

Potential risks and benefits

Taking part in a clinical study always involves weighing potential benefits and risks. The potential benefit to you could have been access to a new valve technology and close monitoring of your heart health. Contributions from participants are vital to furthering medical knowledge and improving treatments for future patients with heart conditions. However, any medical procedure carries risks, such as bleeding, infection, or complications related to the valve replacement. The study was designed to carefully monitor for any issues. It's crucial to remember that you always have the right to withdraw from a study at any time, for any reason, without it affecting your usual medical care.

Locations (75)

  • University of Alabama at Birmingham
    Verified postcode
    Birmingham, United States
  • Banner Good Samaritan
    Verified postcode
    Phoenix, United States
  • HonorHealth Scottsdale Healthcare
    Verified postcode
    Scottsdale, United States
  • TMC HealthCare
    Verified postcode
    Tucson, United States
  • Baptist Health Medical Center
    Verified postcode
    Little Rock, United States
  • Scripps Clinic
    Verified postcode
    La Jolla, United States
  • Kaiser Permanente Los Angeles
    Verified postcode
    Los Angeles, United States
  • Cedars-Sinai Heart Institute
    Verified postcode
    Los Angeles, United States
  • University of California, Davis Medical Center
    Verified postcode
    Sacramento, United States
  • Kaiser Permanente - San Francisco
    Verified postcode
    San Francisco, United States
  • Stanford University Medical Center
    Verified postcode
    Stanford, United States
  • MedStar Washington Hospital Center
    Verified postcode
    Washington D.C., United States

Common questions

What is Aortic Stenosis?

Aortic stenosis is a condition where the main valve in your heart, called the aortic valve, becomes stiff and narrow, making it difficult for blood to flow out of your heart efficiently.

What is TAVR?

TAVR (Transcatheter Aortic Valve Replacement) is a procedure to replace a narrowed aortic valve using a small tube inserted through a blood vessel, usually in the leg, rather than through open-heart surgery.

Was the ACURATE valve experimental?

Yes, in the context of this study, the ACURATE valve was being studied to gather more information about its safety and effectiveness compared to valves already widely used.

Is the ACURATE valve still available?

No, the company that made the ACURATE valve has stopped producing it globally, and it is no longer available.

Why were other valves used for comparison?

Comparing new treatments to established ones helps doctors understand if the new treatment is just as good, or better, and what its specific benefits and risks are.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.